Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin. [electronic resource]
Producer: 20151125Description: 3762-72 p. digitalISSN:- 1530-6860
- Acute Lung Injury -- drug therapy
- Animals
- CCR5 Receptor Antagonists -- pharmacology
- Complement Activation
- Complement C3a -- genetics
- Complement C5a, des-Arginine -- genetics
- Cyclohexanes -- pharmacology
- Leukocytes -- metabolism
- MAP Kinase Kinase 1 -- genetics
- MAP Kinase Kinase 2 -- genetics
- Maraviroc
- Mice
- Mice, Knockout
- Phosphatidylinositol 3-Kinases -- genetics
- Proto-Oncogene Proteins c-akt -- genetics
- Pulmonary Alveoli -- metabolism
- Receptor, Anaphylatoxin C5a -- genetics
- Receptors, CCR5 -- genetics
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.